• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Experts Claim The COVID19 Pandemic Might Last For Seven Years With The Present Rate Of Vaccination

February 9, 2021 by Jennifer Preston Leave a Comment

A recent calculation shows that with the current rate of vaccination it might take seven years before the COVID19 pandemic is over around the world. Experts have made a massive database of COVID19 vaccinations happening across the world. The data shows that it might take a decade to achieve herd immunity against the virus if vaccine rollout plans do not speed up for the two-dose vaccines. Infectious disease experts from the US. Dr. Anthony Fauci has said that at least 70 to 85 percent of populations need to be vaccinated in order to reach herd immunity. With the current rate of vaccination, the US might be able to achieve herd immunity by 2022. However, countries like Canada might take another ten years to reach the goal with the present rate of inoculation. As per the report, around 119 million doses of vaccines have been rolled out across the world but some rich and western countries are on the verge of vaccinating their 75 percent of populations much faster than others. Israel is expected to vaccinate 75 percent of its people by the spring but Portugal might take four years and China might take seven years to achieve herd immunity if vaccine plans are not revamped.

Experts have said that these calculations are volatile especially with vaccine rollouts, which are quite recent and have been spoiled with disrupted supplies. The vaccination rate in Canada has reduced by half, as the country has been facing delays in shipments recently. However, the country has signed contracts with the drug makers to buy more doses per person. Experts who have come up with the data have said that the rate of vaccination worldwide might speed up as more and more doses are available. They have focused on major vaccine manufacturing hubs in India and Mexico and said that only a third of these nations have started vaccine distribution. On the other hand, some experts have said that the calculation has been based on two full doses of vaccines, and as a vaccine from Johnson & Johnson will be approved, which is a single-dose vaccine, these estimates will be tweaked. There are some other limitations to this data. The data includes children as they can be infected and contribute to the spread of the virus but a vaccine for children has not been approved yet.

The data does not account for the people who have some immunity against the disease due to a past infection. The US Centers for Disease Control and Prevention (CDC) has said a past infection provides some immunity against the virus but it is uncertain how long it will last. A past study has noted that reinfection is quite common among young people especially those who have had a mild infection or have shown no symptoms at all during the initial infection. Experts have urged governments across the world to include young and those who have been infected with the bug in the past in their vaccine rollout plans.

Jennifer Preston
Jennifer Preston

Related posts:

  1. Health Experts Say Inoculating Children Will Help In Achieving Herd Immunity Against The COVID19
  2. New threats emerging from Nipah Virus: Health Experts says
  3. The New Strain Of The SARS-CoV-2 Virus Can Spread 70 Percent Faster With The Same Fatal Effect
  4. Use Of Marijuana Increases Up To 75 Percent Among Elderly Americans In The Last 4 Years

Filed Under: Health

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Did People Have Bigger Foreheads In The Past? The Grisly Truth Behind Those Old Paintings
  • After Three Years Of Searching, NASA Realized It Recorded Over The Apollo 11 Moon Landing Footage
  • Professor Of Astronomy Explains Why You Can’t Fire Your Enemies Straight Into The Sun
  • Do We All See The Same Blue? Brilliant Quiz Shows The Subjective Nature Of Color Perception
  • Earliest Detailed Observations Of A Star Exploding Show True Shape Of A Supernova
  • Balloon-Mounted Telescope Captures Most Precise Observations Of First Known Black Hole Yet
  • “Dawn Of A New Era”: A US Nuclear Company Becomes First Ever Startup To Achieve Cold Criticality
  • Meet The Kodkod Of The Americas: Shy, Secretive, And Super-Small
  • Incredible Footage May Be First Evidence Wild Wolves Have Figured Out How To Use Tools
  • Raccoons In US Cities Are Evolving To Become More Pet-Like
  • How Does CERN’s Antimatter Factory Work? We Visited To Find Out
  • Elusive Gingko-Toothed Beaked Whale Seen Alive For First Time Ever
  • Candidate Gravitational Wave Detection Hints At First-Of-Its-Kind Incredibly Small Object
  • People Are Just Learning What A Baby Eel Is Called
  • First-Ever Look At Neanderthal Nasal Cavity Shatters Expectations
  • Traces Of Photosynthetic Lifeforms 1 Billion Years Older Than Previous Record-Holder Discovered
  • This 12,000-Year-Old Artwork Shows An “Extraordinary” Moment In History And Human Creativity
  • World’s First Critically Endangered Penguin Directly Competes With Fishing Boats For Food
  • Parasitic Ant Queens Use Chemical Warfare To Incite Revolutions Against Reigning Queens
  • Data From Mars Lets ESA Predict 3I/ATLAS’s Path 10 Times More Precisely
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version